IKNA Stock IKNA is expected to report earnings to rise+3.05% to -40 cents per share on May 13

A.I.dvisor
at Tickeron.com
05/12/24
Loading...
IKNA - Ikena Oncology
Ikena Oncology Earnings Graph
Q1'24
Est.
$-0.40
Q4'23
Beat
by $0.01
Q3'23
Beat
by $0.03
Q2'23
Beat
by $0.03
Q1'23
Beat
by $0.08
The last earnings report on December 31 showed earnings per share of -41 cents, beating the estimate of -42 cents. P/B Ratio (0.367) is normal, around the industry mean (10.609). P/E Ratio (0.000) is within average values for comparable stocks, (160.883). IKNA's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.422). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (5.879) is also within normal values, averaging (236.959). With 157.68K shares outstanding, the current market capitalization sits at 62.25M.
View a ticker or compare two or three
IKNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com